December 5, 2022
This class action concerns stock ownership in Sinovac (NASDAQ: SVA), a vaccine company the complaint calls “the world’s single largest producer of Covid-19 vaccines.” It brings suit against Sinovac and its founder, president, CEO, and chairman Weidong Yin, for diluting the stock in trying take the company private.
Case Event File: Sinovac (NASDAQ: SVA) Dilution of Stock to Go Private ComplaintRelated to: Sinovac (NASDAQ: SVA) Dilution of Stock to Go Private Class Action